BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Hetlioz (tasimelteon) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Hetlioz (tasimelteon)\, from ClinicalTria
 ls.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06953869-10836@assetmemo.bio
DTSTAMP:20261121T005445Z
DTSTART;VALUE=DATE:20271130
DTEND;VALUE=DATE:20271201
SUMMARY:Hetlioz (tasimelteon): Phase 3 readout est. (NCT06953869)
DESCRIPTION:Hetlioz (tasimelteon)\, phase 3.\nStudy: Evaluating the Effects
  of Tasimelteon vs. Placebo in Treating Pediatric Insomnia\nEstimated prim
 ary completion: November 2027. This is a ClinicalTrials.gov estimate\, not
  a confirmed readout date\, and it can move.\nDrug page: https://assetmemo
 .bio/drug/tasimelteon#upcoming-events\nRegistry record: https://clinicaltr
 ials.gov/study/NCT06953869
URL:https://assetmemo.bio/drug/tasimelteon#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
